Rchr
J-GLOBAL ID：201901005644141893
Update date: Sep. 25, 2024
MASUDA Yuichi
マスダ ユウイチ | MASUDA Yuichi
Affiliation and department：
Job title：
Associate Professor
Research field (1)：
General surgery, pediatric surgery
Papers (9)：
-
Yuichi Masuda, Kazuki Yoshizawa, Yasunari Ohno, Atsuyoshi Mita, Akira Shimizu, Yuji Soejima. Small-for-size syndrome in liver transplantation: Definition, pathophysiology and management. Hepatobiliary Pancreat Disease International. 2020
-
Kiyotaka HOSODA, Yuichi MASUDA, Atsuyoshi MITA, Akira KOBAYASHI. Interferon-free Anti-hepatitis C Virus Treatment for Long-term Liver Transplantation Recipients with Failed Interferon Therapy. Shinshu Medical Journal. 2019. 67. 6. 417-423
-
Yuichi Masuda, Nosratola D. Vaziri, Shiri Li, Aimee Le, Mohammad Hajighasemi-Ossareh, Lourdes Robles, Clarence E. Foster, Michael J. Stamos, Ismail Al-Abodullah, Camillo Ricordi, et al. The Effect of Nrf2 Pathway Activation on Human Pancreatic Islet Cells. PLOS ONE. 2015. 10. 6. e0131012
-
Masuda Y, Vaziri ND, Takasu C, Li S, Robles L, Pham C, Le A, Vo K, Farzaneh SH, Stamos MJ, Ichii H. Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver. Gastroenterol Hepatol (Que). 2014. 1. 1. 1-7
-
Yuichi Masuda, Hirohito Ichii, Nosratola D. Vaziri. At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH. 2014. 6. 1. 64-70
ｍore...
Lectures and oral presentations (3)：
-
Liver Retransplantation Long-Term After Living Donor Liver Transplantation: A Single-Center Experience.
(2014 World Transplant Congress 2014)
-
The effect of Nrf2-keap1 pathway activationon human pancreatic β cells
(American Transplant Congress 2013 2014)
-
The effect of Nrf2-keap1 pathway activation on human pancreatic β cells
(American Transplant Congress 2013 2014)
Professional career (1)：
- Ph. D (Shinshu Univeresity)
Return to Previous Page
